Immunopathology on hepatocyte expression of HBV surface, core, and x antigens in chronic hepatitis B: clinical and virological correlation.
OBJECTIVE
Hepatocyte expression of HBV surface, core, and x antigens (HBsAg, HBcAg and HBxAg), semi-quantitated by immunopathology, were correlated with clinical and virological data in 80 patients with chronic hepatitis B.


RESULTS
Seventy patients were HBsAg positive in cytoplasm, 61 were HBcAg positive, including 45 in both nucleus and cytoplasm and 16 in cytoplasm only, and 47 were HBxAg positive in cytoplasm. The detection rates for HBcAg increased while those for HBsAg and HBxAg decreased with HBV DNA levels. Positive HBcAg staining usually suggested the presence of HBV DNA levels >10(6) copies/ml. HBcAg, HBsAg, and HBxAg expressions showed no significant differences between patients with genotype B and C. Serum HBeAg and HBV DNA levels correlated positively with nuclear or cytoplasmic HBcAg expression but inversely with HBsAg expression. By multiple regression analysis, HBV DNA levels correlated significantly only with nuclear HBcAg expression. ALT levels and inflammatory grades correlated with cytoplasmic HBcAg expression. There was an inverse quantitative relationship between HBcAg and HBsAg expression. Furthermore, HBxAg expression correlated significantly with HBsAg expression as well as male gender.


CONCLUSIONS
With diminishing HBV DNA levels following HBeAg seroconversion, HBcAg expression decreased but HBsAg expression increased with a concomitant increase in HBxAg expression. Whether the finding that a significantly higher expression of HBxAg observed in males than females may account for the gender difference in long-term sequelae of chronic HBV infection needs further investigation.
Chu
Chia-Ming
CM
Liver Research Unit, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, 199 Tung Hwa North Road, Taipei 10591, Taiwan. chiamingchu@yahoo.com.tw
Shyu
Wei-Chue
WC
Liaw
Yun-Fan
YF
D000328:Adult; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D005500:Follow-Up Studies; D005838:Genotype; D006512:Hepatitis B Core Antigens / Q000096:biosynthesis* / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000096:biosynthesis* / Q000276:immunology; D006513:Hepatitis B e Antigens / Q000096:biosynthesis / Q000276:immunology; D006515:Hepatitis B virus / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D019694:Hepatitis B, Chronic / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D022781:Hepatocytes / Q000378:metabolism* / Q000473:pathology / Q000821:virology; D006801:Humans; D008297:Male; D015534:Trans-Activators / Q000096:biosynthesis* / Q000276:immunology; D054334:Viral Regulatory and Accessory Proteins
D004279:DNA, Viral; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D015534:Trans-Activators; D054334:Viral Regulatory and Accessory Proteins; C057628:hepatitis B virus X protein
Hepatology. 1991 Mar;13(3):417-21
1999313
Pathol Oncol Res. 2001;7(3):178-84
11692143
Hepatology. 1991 Jul;14(1):29-37
1712339
Hepatology. 1990 Dec;12(6):1443-5
2258161
World J Gastroenterol. 2003 Dec;9(12):2671-5
14669310
Gastroenterology. 1995 Dec;109(6):1926-32
7498658
Dig Dis Sci. 2008 Nov;53(11):2995-8
18409002
Liver. 1990 Dec;10(6):355-64
2074733
J Clin Microbiol. 2003 Dec;41(12):5598-603
14662947
Hepatology. 1990 Dec;12(6):1278-83
2258144
J Med Virol. 2001 Aug;64(4):419-26
11468725
Hepatology. 2002 Dec;36(6):1408-15
12447866
J Hepatol. 2005 Sep;43(3):411-7
16006001
J Clin Gastroenterol. 2003 Mar;36(3):269-72
12590241
J Hepatol. 1995 Jun;22(6):696-9
7560864
Oncology. 1990;47(2):143-8
2156203
J Korean Med Sci. 1997 Dec;12(6):523-31
9443091
Gastroenterology. 1987 Jan;92(1):220-5
3536652